Different breakpoints interpretation yielded distinct resistance rates to moxifloxacin of clinically significant anaerobic bacteria.
Anaerobe
; 72: 102471, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34715325
ABSTRACT
The aim of this study was to describe the differences in antimicrobial susceptibility to moxifloxacin between European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) in anaerobic microorganisms. Overall, resistance to moxifloxacin appears to be high in almost all groups of anaerobes, but enormous differences in susceptibility rates between these two committees could be observed.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacteria, Anaerobic
/
Bacterial Infections
/
Drug Resistance, Bacterial
/
Moxifloxacin
/
Anti-Bacterial Agents
Type of study:
Guideline
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Anaerobe
Year:
2021
Document type:
Article